Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
EMCORE Corporation is a semiconductors business based in the US. EMCORE Corporation shares (EMKR) are listed on the NASDAQ and all prices are listed in US Dollars. EMCORE Corporation employs 387 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$7.41|
|52-week range||$3.25 - $10.87|
|50-day moving average||$7.31|
|200-day moving average||$7.96|
|Wall St. target price||$13.75|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.64|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-14)||-2.76%|
|1 month (2021-09-21)||12.10%|
|3 months (2021-07-21)||-18.39%|
|6 months (2021-04-21)||18.18%|
|1 year (2020-10-21)||99.73%|
|2 years (2019-10-21)||159.09%|
|3 years (2018-10-19)||46.73%|
|5 years (2016-10-21)||20.49%|
Valuing EMCORE Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of EMCORE Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
EMCORE Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 12x. In other words, EMCORE Corporation shares trade at around 12x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
EMCORE Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.08. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into EMCORE Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
EMCORE Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $19.3 million.
The EBITDA is a measure of a EMCORE Corporation's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$148 million|
|Operating margin TTM||10.21%|
|Gross profit TTM||$35.6 million|
|Return on assets TTM||6.36%|
|Return on equity TTM||20.92%|
|Market capitalisation||$280.3 million|
TTM: trailing 12 months
There are currently 993,365 EMCORE Corporation shares held short by investors – that's known as EMCORE Corporation's "short interest". This figure is 6.7% down from 1.1 million last month.
There are a few different ways that this level of interest in shorting EMCORE Corporation shares can be evaluated.
EMCORE Corporation's "short interest ratio" (SIR) is the quantity of EMCORE Corporation shares currently shorted divided by the average quantity of EMCORE Corporation shares traded daily (recently around 281406.51558074). EMCORE Corporation's SIR currently stands at 3.53. In other words for every 100,000 EMCORE Corporation shares traded daily on the market, roughly 3530 shares are currently held short.
However EMCORE Corporation's short interest can also be evaluated against the total number of EMCORE Corporation shares, or, against the total number of tradable EMCORE Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case EMCORE Corporation's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 EMCORE Corporation shares in existence, roughly 30 shares are currently held short) or 0.0374% of the tradable shares (for every 100,000 tradable EMCORE Corporation shares, roughly 37 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against EMCORE Corporation.
Find out more about how you can short EMCORE Corporation stock.
We're not expecting EMCORE Corporation to pay a dividend over the next 12 months.
EMCORE Corporation's shares were split on a 1:4 basis on 15 February 2012. So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your EMCORE Corporation shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for EMCORE Corporation shares which in turn could have impacted EMCORE Corporation's share price.
Over the last 12 months, EMCORE Corporation's shares have ranged in value from as little as $3.25 up to $10.87. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while EMCORE Corporation's is 1.2608. This would suggest that EMCORE Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
EMCORE Corporation, together with its subsidiaries, provides advanced mixed-signal optics products in the United States, Canada, Asia, Europe, and internationally. The company offers cable television (CATV) products, including forward and return-path analog lasers, receivers, photodetectors, and subassembly components; and analog and digital fiber-optic transmitters, quadrature amplitude modulation transmitters, optical switches, and CATV fiber amplifiers. It also provides high-power gain chips products, photodiode products, and GPON fiber-to-the-premises (FTTP) and data center chip products for the telecommunication markets, as well as lasers, receivers, and photodetector components for wireless, distributed sensing, and light detecting and ranging applications. In addition, the company offers navigation system and inertial sensing products, such as fiber optic gyroscope, quartz MEMS gyroscope, and inertial measurement unit and navigation system primarily for the aerospace and defense markets; and defense optoelectronics, such as optiva platform fiber optic transport systems and erbium doped fiber amplifiers, as well as ruggedized microwave flange-mount transmitters, receivers, and optical delay line products. It serves CATV, wireless, FTTP, long-term evolution, and data center markets; and aerospace and defense and satellite communications markets. The company sells its products through direct sales force, application engineers, third party sales representatives, and distributors. EMCORE Corporation was founded in 1984 and is headquartered in Alhambra, California.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.